These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1780687)

  • 1. Serum TATI levels and clinical correlation in tumors of the head and neck.
    Rayo JI; Garcia-Talavera JR; Martin M; Muñoz A; Del Cañizo A
    Scand J Clin Lab Invest Suppl; 1991; 207():33-5. PubMed ID: 1780687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
    Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated trypsin inhibitor (TATI) in the diagnosis of lung cancer.
    Pecchio F; Rapellino M; Baldi S; Casali V; Libertucci D; Coni F
    Scand J Clin Lab Invest Suppl; 1991; 207():63-4. PubMed ID: 1780695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated trypsin inhibitor and renal cell carcinoma.
    Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
    Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological diseases.
    Torre GC; Rembado R; Barbetti V; Vigliercio GP; Foglia M; Calabrese A; Corongiu F
    Scand J Clin Lab Invest Suppl; 1991; 207():15-8. PubMed ID: 1780684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated trypsin inhibitor (TATI) in bone diseases.
    Rapellino M; Pecchio F; Broggi S; Baldi C; Ricardi G; Libertucci D
    Scand J Clin Lab Invest Suppl; 1991; 207():65-6. PubMed ID: 1780696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancer.
    Pectasides D; Bourazanis J; Economides N; Pozadzidou P; Gogou L; Koutsiouba P; Athanassiou A
    Int J Biol Markers; 1993; 8(2):81-7. PubMed ID: 8366300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease.
    Loizate Toricaguena A; Lamiquiz Vallejo A; Dominguez Merru-Urrutia MJ; Legorburu Escudero JF
    Scand J Clin Lab Invest Suppl; 1991; 207():59-62. PubMed ID: 1780694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tumor-associated trypsin inhibitor (TATI) in women with benign and malignant gynecological disease.
    Inaudi P; Petrilli S; De Leo V; Bernabei A; Pasqui L; D'Antona N
    Scand J Clin Lab Invest Suppl; 1991; 207():11-3. PubMed ID: 1780683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis.
    Medl M; Ogris E; Peters-Engl C; Mierau M; Buxbaum P; Leodolter S
    Br J Obstet Gynaecol; 1997 Jan; 104(1):78-81. PubMed ID: 8988701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated trypsin inhibitor in pancreatic diseases.
    Aroasio E; Piantino P
    Scand J Clin Lab Invest Suppl; 1991; 207():71-3. PubMed ID: 1723534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of TATI and other markers in solid tumors.
    Taccone W; Mazzon W; Belli M
    Scand J Clin Lab Invest Suppl; 1991; 207():25-32. PubMed ID: 1780686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Klockars M; Pettersson T; Fröseth B; Selroos O; Stenman UH
    Chest; 1990 Nov; 98(5):1159-64. PubMed ID: 2225961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated trypsin inhibitor (TATI) in pleural effusions.
    Rapellino M; Pecchio F; Baldi S; Adamo MR; Macri M; Ricardi G
    Scand J Clin Lab Invest Suppl; 1991; 207():47-9. PubMed ID: 1780690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.
    Plebani M; Basso D; Fabris C; Meggiato T; Del Favero G; Panozzo MP; Fogar P; Faggian D; Angonese C; Burlina A
    Klin Wochenschr; 1989 Oct; 67(20):1029-32. PubMed ID: 2586008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
    Kasurinen A; Laitinen A; Kokkola A; Stenman UH; Böckelman C; Haglund C
    Acta Oncol; 2020 Jun; 59(6):681-688. PubMed ID: 32124669
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases.
    Piantino P; Arosaio E
    Scand J Clin Lab Invest Suppl; 1991; 207():67-9. PubMed ID: 1780697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma.
    Gion M; Mione R; Tremolada C; Dalla Palma P; Ruol A; Dittadi R; Leon A; Nosadini A; Castoro C; Bruscagnin G
    Scand J Clin Lab Invest Suppl; 1991; 207():37-41. PubMed ID: 1780688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.